← Evidence map

ReviewDrugs & therapy perspectives : for rational drug selection and use2023

Nirmatrelvir plus ritonavir in COVID-19: a profile of its use.

Hannah A BlairPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36532315